Schrödinger, Inc. (SDGR)

NMS – Real Time Price. Currency in USD

18.50

-0.15 (-0.83%)

Market open: Aug 12, 2026, 1:12 PM EDT

18.43

-0.22 (-1.18%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

06.08.2026

Schrodinger Q2 Earnings Call Highlights

Schrodinger NASDAQ: SDGR said second-quarter annual contract value growth accelerated as demand broadened across large pharmaceutical customers, biotechnology companies and materials-science customers, while the company launched early access for Bunsen, its agentic AI co-scientist.

06.08.2026

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrodinger, Inc. (SDGR) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.6 per share. This compares to a loss of $0.59 per share a year ago.

05.08.2026

Schrödinger Reports Second Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Today Schrödinger announced financial results for the quarter ended June 30, 2026.

05.08.2026

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization.

04.08.2026

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Schrödinger is challenging the incumbent drug-trial method—physics-simulated molecular design that cuts the cost, time, and animal testing of building and screening thousands of candidates. The current EV is roughly accounted for by the software leg alone - the royalties business and the disruption TAM are barely priced in, if at all. Three drivers - a regulatory push away from animal testing, AI-led consumption growth, and Bunsen - open up asymmetric upside that is not required for the base case.

Videos

No Data

There is no data to display

Press releases

05.08.2026

Schrödinger Reports Second Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Today Schrödinger announced financial results for the quarter ended June 30, 2026.

05.08.2026

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization.

Schrödinger, Inc. (SDGR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Schrödinger, Inc. (SDGR)

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger Q2 Earnings Call Highlights

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Videos

No Data

Press releases

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger Q2 Earnings Call Highlights

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Videos

No Data

Press releases

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Search stocks

Schrödinger, Inc. (SDGR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Schrödinger, Inc. (SDGR)

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger Q2 Earnings Call Highlights

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Videos

No Data

Press releases

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger Q2 Earnings Call Highlights

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It

Videos

No Data

Press releases

Schrödinger Reports Second Quarter 2026 Financial Results

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery